Literature DB >> 22372902

Mesothelioma not associated with asbestos exposure.

Bharat Jasani1, Allen Gibbs.   

Abstract

CONTEXT: Despite asbestos being identified as the single most important cause of malignant mesothelioma, the tumor is known to occur in only 10% to 20% of heavily exposed individuals. In addition, about 20% of the patients have no history of asbestos exposure even after detailed assessment. Therefore, there has been speculation for some time that asbestos alone may not be sufficient to cause mesothelioma and that other factors may be involved either as cocarcinogens or as independent mechanisms of cancer causation.
OBJECTIVE: To give a brief review of nonasbestos fiber erionite and therapeutic radiation as 2 established examples of asbestos-independent mechanisms, of the potential emerging role of man-made fibers such as carbon nanotubes, and of polyoma virus SV40 (simian virus 40) as a potential example of the cocarcinogenic mode of involvement. DATA SOURCES: Relevant recent literature has been surveyed to portray and provide the evidence in favor of the examples.
CONCLUSIONS: Erionite has emerged as the most important example of nonasbestos-mediated cause of mesothelioma in regions such as Turkey where exposure to this type of fiber is highly prevalent. Recently, the polyoma virus SV40 has been unexpectedly discovered as an effective cocarcinogen of asbestos in the causation of animal mesothelioma, though despite considerable research, its potential role in human mesothelioma remains unproven.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372902     DOI: 10.5858/arpa.2011-0039-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  21 in total

1.  Malignant mesothelioma of tunica vaginalis: an extremely rare case presenting without risk factors.

Authors:  Y Akin; I Bassorgun; I Basara; S Yucel
Journal:  Singapore Med J       Date:  2015-03       Impact factor: 1.858

2.  A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer.

Authors:  Mitsutake Yano; Yuji Ikeda; Tomomi Kato; Mika Sakaki; Sho Sato; Akira Yabuno; Eito Kozawa; Masanori Yasuda
Journal:  Mol Clin Oncol       Date:  2017-12-06

3.  Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.

Authors:  Alain C Borczuk; Jianming Pei; Robert N Taub; Brynn Levy; Odelia Nahum; Jinli Chen; Katherine Chen; Joseph R Testa
Journal:  Cancer Biol Ther       Date:  2016-02-06       Impact factor: 4.742

4.  Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens.

Authors:  Akif Burak Tosun; Oleksandr Yergiyev; Soheil Kolouri; Jan F Silverman; Gustavo K Rohde
Journal:  Cytometry A       Date:  2015-01-16       Impact factor: 4.355

5.  Pleural Mesothelioma with No Asbestos Exposure: A Case Report.

Authors:  Salma Ait Batahar; Othmane Ouradi; Safae Elidrissi; Lamyae Amro
Journal:  J Clin Diagn Res       Date:  2016-11-01

Review 6.  New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Authors:  Brooke T Mossman; Arti Shukla; Nicholas H Heintz; Claire F Verschraegen; Anish Thomas; Raffit Hassan
Journal:  Am J Pathol       Date:  2013-02-08       Impact factor: 4.307

7.  Unusual presentation and location pleural malignant mesothelioma.

Authors:  Anjan Kumar; Carolina Carcano; Anas Hadeh; Rogerio Lilenbaum
Journal:  BMJ Case Rep       Date:  2013-06-10

Review 8.  Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

Authors:  Volker Neumann; Stefan Löseke; Dennis Nowak; Felix J F Herth; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2013-05-03       Impact factor: 5.594

Review 9.  The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms.

Authors:  Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Tumour Biol       Date:  2013-10-01

Review 10.  Scientific Advances and New Frontiers in Mesothelioma Therapeutics.

Authors:  Luciano Mutti; Tobias Peikert; Bruce W S Robinson; Arnaud Scherpereel; Anne S Tsao; Marc de Perrot; Gavitt A Woodard; David M Jablons; Jacinta Wiens; Fred R Hirsch; Haining Yang; Michele Carbone; Anish Thomas; Raffit Hassan
Journal:  J Thorac Oncol       Date:  2018-09       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.